3 Comments

Thank you Jason for your insights on similarities between the biopharma and mCDR industries! I really appreciate the ability to recognize the similarities between the (somewhat nascent) CDR space and more mature industries, all while being able to apply 'lessons learned' from them towards CDR.

Expand full comment

Here is another difference: the equilibration time scale for ANY mCDR (the time it takes for air CO2 to fully dissolve into the ocean in response to the mCDR) is up to 18 months by which time the signal has dissipated - it is not measurable. Imagine a drug whose effect on the patient is unmeasurable!

Expand full comment

Thank you Jason.

Very interesting analysis. In terms of economics, I would like to propose a slightly different angle. As any other product, mCDR (or CDR in general) should have solid economical basis. It needs to save money or it needs to generate revenues for its customers (ideally, both). mCDR (CDR in general) cannot rely upon ever changing carbon credit market which is not even yet regulated. What does it mean? It requires to generate a product. A real (by)product.

Expand full comment